(R)-1-(4-chlorophenyl)-2,2,2-trifluoroethanamine, 96%, 1g

(4-Fluorophenyl)(p-tolyl)methanone, 95.0%, 1g

1-Butyl-2-methyl-4-nitro-1H-imidazole, 97%, 1g

2-Morpholin-4-yl-5-nitro-benzaldehyde, 95.0%, 5g

Rociletinib, 99%, 5mg

PTFE sealing cord 2.50 m

5-methylpyrazolo[1,5-a]pyridine-2-carboxylic acid, 95.0%, 1g

2-Amino-5-bromo-3-iodobenzonitrile, 95.0%, 25g

4-Bromo-2-(chloromethyl)-1-iodobenzene, 95.0%, 250mg

1-Isopropyl-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 250mg

N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide, 25mg

6-(2,6-Dichloro-phenyl)-2-[4-(2-diethylaMino-ethoxy)-phenylaMino]-8-Methyl-8H-pyrido[2,3-d]pyriMidin-7-one, 99%, 25mg

2,2,2-Trifluoro-1-(2-(methylamino)phenyl)ethanone, 95.0%, 250mg